You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | 0.0% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -12.2 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 0.0 | 0.0 |
Price / Book value | 118.5 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | 0.95 | -10.06 | €-0.42 | -7.4 | 0.0 | n/a | n/a | 0.0% |
2017-12-31 | n/a | -21.06 | €-0.76 | -11.8 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | n/a | -13.25 | €-0.31 | -10.0 | 0.0 | n/a | n/a | 0.0% |
FDA approves next two phases of Faron's Traumakine trial Sharecast News | 26 Jan |
---|---|
Faron gets Traumakine funding from US Department of Defense Sharecast News | 18 Jan |
Faron Pharmaceuticals gets Finnish state loan for manufacturing process Sharecast News | 15 Jun |
Faron to Present at H.C. Wainwright Conference | 02-Mar-21 07:00 |
---|---|
Notice of Full-Year Results and Annual Report | 25-Feb-21 07:01 |
Holding(s) in Company | 17-Feb-21 16:30 |
Registration of Placing Shares | 12-Feb-21 15:00 |
Results of Placing and Issue Price | 12-Feb-21 12:46 |